Social media

Quality and compliance shape every part of clinical research. For anyone considering a career in this field, understanding these foundations can make the path ahead clearer and more rewarding. Our latest blog explain...

We’re proud to share that Sanofi and Symphony Health, an ICON plc company, have published a peer-reviewed study in JMIR leveraging Symphony Health’s real-world claims data to evaluate the impact of Dario’s digital diabet...

We’re excited to share groundbreaking research from Sanofi and Symphony Health, an ICON plc company, published in JMIR! Using Symphony Health’s real-world claims data, the study shows that Dario’s digital diabetes solut...

Site activation delays cost trials time and trust. ICON’s new whitepaper shows how human-centred strategies accelerate startup and improve site satisfaction. Download now: https://ow.ly/j6RK50XB6ZW

Site activation can take months. Learn how ICON is helping sponsors cut timelines in half with AI-powered tools and site-centric planning. Read the whitepaper: https://ow.ly/f5EO50XB6ZL

USP compounding may be fast — but is it costing you quality, compliance, and insight? In this insightful session, our experts discussed: - Why GMP manufacturing offers a strategic edge in early phase trials - Real-worl...

For medical device developers selecting the right AI model and data is crucial to capitalise on this powerful technology. Our new whitepaper explains best practices for AI-enabled devices. Learn about AI models, datase...

Do you know the difference between decision trees and random forests? Learn about AI models for SaMDs in our new whitepaper. Download it now to learn best practices for model and data selection. https://ow.ly/nI8g50XAzbq

Attending #ASH25? Stop by booth \#2161 to meet the ICON team and discuss how our extensive testing capabilities, clinical research experience and scientific expertise can support global oncology and haematology research ...

ICON was amongst several leading Irish businesses that participated in the first Ireland-Ukraine Economic Forum: https://lnkd.in/eQmATh-f

The CRA role is evolving—from data checker to strategic partner. ICON’s Helen Yeardley explores how technology is reshaping clinical trial oversight. Read the Applied Clinical Trials article: https://ow.ly/paW350XB6R6

Because existing HIV therapies are already highly effective when taken as prescribed, traditional trial settings often fail to reveal the added value of emerging approaches. Explore how developers can plan trials that ...